Bio-Thera Solutions Announces BAT8006 (Folate-Receptor-?-ADC) and BAT8008 (Trop2-ADC) Poster Presentations at the 2022 San Antonio Breast Cancer Symposium
GUANGZHOU, China--(BUSINESS WIRE)--#ADC--Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and…